最近の急性心筋梗塞の入院例の減少は,メディケア有料サービス受給者のための進歩と継続的な課題です
Jersey Chen1, Sharon-Lise T Normand, Yun Wang
1Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA. jersey.chen@yale.edu
Circulation
|March 10, 2010
まとめ
急性心筋梗塞 (AMI) の入院率は,2002年から2007年にかけて,米国メディケアの料金対サービス患者で著しく減少しました. しかし,黒人男性と黒人女性の減少率は,白人男性と比べて遅かった.
科学分野:
- 心臓病学 心臓病学
- 公衆衛生は公衆衛生である.
- ゲリアトリック・メディシン (老年医学)
背景:
- 心血管疾患は依然として死亡の主な原因である.
- 急性心筋梗塞 (AMI) の傾向を理解することは,公衆衛生イニシアチブにとって極めて重要です.
- 高齢者のAMI入院傾向に関するデータは限られている.
研究 の 目的:
- 米国メディケア有料患者における急性心筋梗塞 (AMI) の入院率の動向を調査する.
- 2002年から2007年の間に年齢,性別,人種によってこれらの傾向を分析する.
主な方法:
- 2002年から2007年までのメディケア料金対サービス入院データを活用した.
- 10万受益者年あたりの年間AMI入院率を計算した.
- 雇用されたポアソン回帰分析,年齢,性別,人種によって層分化.
主要な成果:
- AMIの全般的な入院率は,2002年から2007年にかけて23.4%減少した.
- AMI入院率の調整された年間減少率は5.8%でした.
- 白人男性と女性は,黒人男性と女性よりもAMI入院率が大きく減少しました.
結論:
- 医療保険料対サービス人口で観察されたAMI入院の有意な減少.
- 人種集団の間で減少率の格差が認められ,黒人の個人はより遅い改善を示した.
関連する概念動画
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...